Pacific Edge | PEB - Sales Revenues

Stock Price
0.18
Daily Change
0.004 2.22%
Monthly
-23.33%
Yearly
47.20%
Q1 Forecast
0.19

Pacific Edge reported NZD5.94M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025